Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC)
Kiril Trpkov(University of Calgary), Tarek A. Bismar(University of Calgary), Neriman Gökden(University of Arkansas for Medical Sciences), Anthony J. Gill(The University of Sydney), Bryan Donnelly, Adeboye O. Osunkoya(Emory University), José I. López(BioCruces Health research Institute), Ondřej Hes(Charles University), Mathilde Sibony(Environmental Protection Agency), Isabela Werneck da Cunha(AC Camargo Hospital), Jesse K. McKenney(Cleveland Clinic), Xavier Leroy(Domain Therapeutics (France)), Éva Compérat(Vienna General Hospital), Gabriella Nesi(Institut Català d'Ornitologia), Daniel M. Berney(Queen Mary University of London), Daniel Abensur Athanazio(Universidade Federal da Bahia), Ming Zhou(Indiana University School of Medicine), Aslı Yilmaz(University of Calgary), Eric Hyndman, M. Musto, Hatem Abou–Ouf(University of Calgary)
Cited by 150
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k